n.a.

n.a. - n.a.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2018-000495-15-IT

Enrollment

400

Registered

2021-09-30

Start date

2018-05-22

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

xxxxxx MedDRA version: 21.0 Level: PT Classification code 10010011 Term: Colonoscopy normal System Organ Class: 10022891 - Investigations

Interventions

Trade Name: SELG ESSE - 7.3 G POLVERE PER SOLUZIONE ORALE 20 BUSTINE Product Name: SELG ESSE Product Code: n.a. Pharmaceutical Form: Powder for oral suspension INN or Proposed INN: MACROGOL 4000 CAS N

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: xxxxxx Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 300 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 100

Exclusion criteria

Exclusion criteria: xxxxxx

Design outcomes

Primary

Measure	Time frame
Main Objective: xxxxxx;Secondary Objective: xxxxxx;Primary end point(s): xxxxx;Timepoint(s) of evaluation of this end point: xxxxx	—

Secondary

Measure	Time frame
Secondary end point(s): xxxxxxx;Timepoint(s) of evaluation of this end point: xxxxxxx	—

Countries

Italy

Contacts

Public Contactn.a.

IRCCS Istituto Clinico Humanitas

luciano.ravera@humanitas.it0282241

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026